Condition
Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type clinical trials that are recruiting, in United States. By phase: Phase 2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 1Country
Newest Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Using golcadomide and rituximab to prepare patients for CAR T-cell therapy in aggressive B-cell lymphoma | Phase 2 | Scottsdale, Arizona and 6 other locations | Recruiting | Feb 19, 2025 |
| ViPOR combination therapy for relapsed or refractory aggressive B‑cell lymphoma | Phase 2 | Tucson, Arizona and 114 other locations | Recruiting | Oct 21, 2024 |
| Tegavivint treatment for patients with relapsed or refractory large B-cell lymphoma | Phase 1 | Columbus, Ohio | Recruiting | Mar 6, 2023 |
All recruiting trials (3)
-
Using golcadomide and rituximab to prepare patients for CAR T-cell therapy in aggressive B-cell lymphoma
This study is testing if a combination of golcadomide and rituximab can help patients with aggressive B-cell lymphoma get ready for CAR T-cell therapy.
-
ViPOR combination therapy for relapsed or refractory aggressive B‑cell lymphoma
This treatment will try a five‑drug targeted combination called ViPOR (venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide) in adults whose aggressive B‑cell lymphoma has relapsed or not responded to prior therapy, focusing on specific genetic subtypes like CD10‑negative DLBCL and high‑grade B‑cell lympho
-
Tegavivint treatment for patients with relapsed or refractory large B-cell lymphoma
This study is testing a new treatment called tegavivint to see if it can help people with relapsed or refractory large B-cell lymphoma feel better and how much of the drug is safe to use.
Related topics
Quick answers
How many Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.